The impact of fatigue and treatment with ursodeoxycholic acid on the prognosis of primary biliary cirrhosis: an extended 9 year follow-up.
Shouval
Daniel
D
Liver Unit, Hadassah-Hebrew University Hospital, Jerusalem, Israel.
D005221:Fatigue / Q000401:mortality*; D005500:Follow-Up Studies; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy / Q000401:mortality*; D011379:Prognosis; D013997:Time Factors; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D014580:Ursodeoxycholic Acid